Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07390591 · ClinicalTrials.gov registry record

Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms

A clinical trial of Spinal Cord Injuries and Neurogenic Bladder, sponsored by Medstar Health Research Institute.

Recruiting
Registry status
60
Enrollment target
1
Study location

NCT07390591: Recruiting study of Spinal Cord Injuries and Neurogenic Bladder, sponsored by Medstar Health Research Institute.

NCT07390591 is a study of Spinal Cord Injuries and Neurogenic Bladder that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 60 participants, roughly in line with the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07390591, a study of Spinal Cord Injuries and Neurogenic Bladder, is actively recruiting participants, sponsored by Medstar Health Research Institute.

RECRUITING
Registry status
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health. The study aims to understand the perceived benefits, challenges, and opportunities related to Lactobacillus-only, gentamicin-only, and combined gentamicin-Lactobacillus instillations. The main question this study seeks to answer is: 1\. Determine patient and caregivers' preferences, and overall experiences regarding intravesical therapeutics for urinary symptoms and UTI Researchers will compare responses from four groups: participants who have used Lactobacillus-only instillations, gentamicin-only instillations, combined gentamicin-Lactobacillus instillations, and caregivers who have experience supporting instillations. Participants will take part in a one-hour semi-structured interview and may be contacted for brief follow-up discussions to clarify findings. Interviews will be audio-recorded, transcribed, and analyzed using qualitative data software to identify themes related to treatment preferences and acceptability.

Primary Outcome

Qualitative interviews will be coded, and themes how to advance intravesical instillation for urinary health will emerge.

Study Locations (1)

District of Columbia

  • Medstar National Rehabilitation Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-06-19
Est. Completion 2027-09
Medstar Health Research Institute

115 total trials

What NCT07390591 shows while recruiting

NCT07390591 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target.

The record links to 3 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 0 interventions.

NCT07390591 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT07390591 about?

NCT07390591 is a clinical study titled "Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms". The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health. The study aims to understand t...

What is the current status of trial NCT07390591?

This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2025-06-19. Estimated completion is 2027-09.

What conditions does trial NCT07390591 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Lower Urinary Tract Dysfunction.

Who is sponsoring clinical trial NCT07390591?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07390591 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07390591's enrollment target sits among peer trials

60 48th of 202 higher than 145 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT07390591, the US trial registry maintained by the National Library of Medicine. NCT07390591 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.